| Digg It |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Careers Employment > Know It Before You Are Handed The Pink Slip |
|
Digg It - Know It Before You Are Handed The Pink Slip
“When death cometh calling, it cometh not empty handed, it also brought the pink slip.” I think this is the remark of a person who did not even care to read the signals regarding his imp According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product ending layoff. Even though I am not suggesting that he doesn’t deserve to continue in his job for some reason, we can’t forget the body blow that job loss delivers. Events Leading Up To ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in Layoffs You can’t expect the sequence of events to be long enough for you to notice that something is brewing. The timeframe could be very short or your name could be added to the long l lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. ist in the case of a mass layoff. However, the situations vary from time to time and from employer to employer. The following indications might be helpful for you to prepare for the worst here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe and your next steps: 1. OVERALL ECONOMIC SITUATION: All depressions, recessions and general downturns have caused lots of job losses regardless of their timing. In gradually slipping ec d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro onomies, the results manifest themselves on the performance of companies. Unfortunately, sudden economic emergencies such as the ones created in the immediate aftermath of 9/11 can’t be a ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc nticipated. 2. COMPANY LOSING OUT TO THE COMPETITION: This circumstance develops over a time period that can’t be missed. If there is no sight of recovery or at least attempts by managem easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi ent to turn things around, you can try to correlate the turn around possibility to your survival. You have enough time to plan in advance in this situation. 3. YOUR COMPANY MERGED WITH A nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically NOTHER ONE: Mergers and acquisitions across all business sectors are causing sleepless nights to employees. It is more or less certain that some will lose their job when this comes throug and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ h. Especially when you are in a key, decision-making position such as Finance Controller, General Manager etc. 4. ASIAN ECONOMIC DEBACLE: Although still rare, this is considerably gainin ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi g some proportion of job loss threat. Multinational corporations which have invested in Asian growing economies took a beating when the countries’ economies plunged into darkness in the m ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a id 1990s. The repercussions were then felt here in the form of pink slips. Internal Indicators You Must Fear There will be sufficient indications even from within. Silently, employers p dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod repare the ground for your termination. The case will be slightly different in mass layoffs. If you are the lone employee to go, it will not be easy for the employer to do so, especially cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin when the company is healthy. Your boss creates the ground to prove your inability and inefficiency. This is called stage 1 of pink slip preparation. You are asked to accomplish the impos tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen sible. The attempt will be so intense that they want to see you fail in most or all areas. Shirks, frowns and stares take the place of nods, smiles and glances. You are insulted in front t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel of colleagues on what would have been overlooked earlier. In stage 2, you feel blank, suddenly not having the usual workload at all. The idea here is to build frustration in you when cow ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust orkers continue to have a normal workload. You are side stepped in routine meetings and left out of critical company/departmental updates. Mass Layoffs In mass layoffs and lockouts, the y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products workload stops, section by section. Staff suddenly goes missing and people get their pink slips in bulk. There could be a sudden increase in activities to finish off the pending work or . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de to safeguard the interests of the employers. As the company is protecting its interests, you also need to protect yours. Chief among these is remaining employed, or being able to react elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip in enough time to secure alternative employment. It is in your best interest to be alert to possible signs that you could be given the pink slip. Never think that it can’t happen to you tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Dog Business is More Than Doggie Poo How to Save Your Company with Preventative Service Maintenance Tricky Pharmaceutical Sales Interview Questions: Question #1 of 7, How to Identify and Answer
|